Inventor

KULTGEN STEVEN G

US11 patents

⚠️ This page may combine multiple inventors who share the name “KULTGEN STEVEN G”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

TOLERO PHARMACEUTICALS INC

2 patents

US10392392B2Aug 27, 2019

Substituted imidazo[1,2-B]pyridazines as protein kinase inhibitors

TOLERO PHARMACEUTICALS INC2 citations71

US10047093B2Aug 14, 2018

Substituted imidazo[1,2-B]pyridazines as protein kinase inhibitors

TOLERO PHARMACEUTICALS INC3 citations71

VENENUM BIODESIGN LLC

2 patents

US10654834B2May 19, 2020

Non-systemic TGR5 agonists

VENENUM BIODESIGN LLC3 citations68

US11236055B2Feb 1, 2022

Non-systemic TGR5 agonists

VENENUM BIODESIGN LLC0 citations47

PHARMACOPEIA DRUG DISCOVERY

2 patents

US7037916B2May 2, 2006

Pyrimidine derivatives as IL-8 receptor antagonists

PHARMACOPEIA DRUG DISCOVERY3 citations61

US6900213B2May 31, 2005

Bisaryl derivatives having FSH modulatory activity

PHARMACOPEIA DRUG DISCOVERY5 citations60

XU YONG

1 patent

US9416132B2Aug 16, 2016

Substituted imidazo[1,2-b]pyridazines as protein kinase inhibitors

XU YONG3 citations72

SUMITOMO DAINIPPON PHARMA ONCOLOGY INC

1 patent

US10875864B2Dec 29, 2020

Substituted imidazo[1,2-B]pyridazines as protein kinase inhibitors

SUMITOMO DAINIPPON PHARMA ONCOLOGY INC1 citations71

ORGANON NV

1 patent

US7960365B2Jun 14, 2011

Compounds with medicinal effects due to interaction with the glucocorticoid receptor

ORGANON NV2 citations54

ROUGHTON ANDREW LAIRD

1 patent

US8211927B2Jul 3, 2012

5-phenyl-isoxazole-3-carboxamide derivatives as TRPV1 modulators

ROUGHTON ANDREW LAIRD2 citations53

PHARMACOPEIA DRUG DISCLOVERY I

1 patent

US7084154B2Aug 1, 2006

2-(aminomethyl) arylamide analgesics

PHARMACOPEIA DRUG DISCLOVERY I0 citations43